MetadataShow full item record
JournalLancet (London, England)
AbstractLeishmaniasis is a poverty-related disease with two main clinical forms: visceral leishmaniasis and cutaneous leishmaniasis. An estimated 0·7-1 million new cases of leishmaniasis per year are reported from nearly 100 endemic countries. The number of reported visceral leishmaniasis cases has decreased substantially in the past decade as a result of better access to diagnosis and treatment and more intense vector control within an elimination initiative in Asia, although natural cycles in transmission intensity might play a role. In east Africa however, the case numbers of this fatal disease continue to be sustained. Increased conflict in endemic areas of cutaneous leishmaniasis and forced displacement has resulted in a surge in these endemic areas as well as clinics across the world. WHO lists leishmaniasis as one of the neglected tropical diseases for which the development of new treatments is a priority. Major evidence gaps remain, and new tools are needed before leishmaniasis can be definitively controlled.
- Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives.
- Authors: Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA
- Issue date: 2015 Dec
- Leishmaniasis in immunosuppressed individuals.
- Authors: van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J
- Issue date: 2014 Apr
- Leishmaniasis and poverty.
- Authors: Alvar J, Yactayo S, Bern C
- Issue date: 2006 Dec
- Leishmaniasis: new insights from an old and neglected disease.
- Authors: Antinori S, Schifanella L, Corbellino M
- Issue date: 2012 Feb
- Leishmaniasis chemotherapy--challenges and opportunities.
- Authors: Croft SL, Olliaro P
- Issue date: 2011 Oct